Related Experiment Video
Updated: Feb 19, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Patients' preferences for new versus old anticoagulants: a mixed-method vignette-based study.
Beata Bajorek1,2, Brooke Saxton1, Elizabeth Anderson3
11 Graduate School of Health, University of Technology Sydney, Broadway, NSW, Australia.
Patients generally prefer their current anticoagulant, whether warfarin or direct oral anticoagulants (DOACs). Familiarity and monitoring influence choices, with many reluctant to switch therapies.
Area of Science:
- Pharmacology
- Geriatric Medicine
- Patient Experience
Background:
- Differences between warfarin and direct oral anticoagulants (DOACs) impact treatment selection and management.
- Patient and clinician understanding of anticoagulant therapy is crucial for adherence.
Purpose of the Study:
- To investigate patient preferences between warfarin and DOAC therapy.
- To explore patient satisfaction with current anticoagulant treatments.
Main Methods:
- A mixed-method study involving hospitalized older patients on anticoagulants.
- Vignette-based questionnaires and thematic analysis of interviews were employed.
Main Results:
- Most patients preferred their current anticoagulant (warfarin or DOAC) and were reluctant to switch.
- Warfarin users valued familiarity and INR monitoring; DOAC users cited previous bleeding events.
- DOAC users reported higher satisfaction scores than warfarin users.
Conclusions:
- Patient preference is strongly tied to their current anticoagulant regimen.
- Factors like monitoring frequency and past adverse events significantly influence anticoagulant choice.
- Individualized approaches are necessary, considering patient familiarity and experiences.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Bioavailability Study Design: Healthy Subjects Versus Patients
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Cardiovascular Drugs: Classification based on Therapeutic Indications

